TMSL T. Rowe Price Small-Mid Cap ETF

T. Rowe Price Small-Mid Cap ETF (TMSL) currently reports 283 stock positions (subject to change), placing it in the broadly diversified range by holdings breadth. The top line-up is THC (1.15%), BPOP (1.11%), NVT (1.06%), with THC as the largest single weight at 1.15%. Together, the top three holdings account for 3.32%, which indicates that performance drivers are distributed more evenly across the broader basket. This architecture allows the fund to express a clear investment thesis at the top while relying on the broader basket to manage idiosyncratic volatility.

From a capital efficiency perspective, ROIC is 0.87%, WACC is 8.85%, and the economic spread is -7.98%. On balance, holdings are currently generating returns below their cost of capital, which may weigh on intrinsic value over time. Supporting metrics show ROE at 9.19% and ROA at 3.32%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio that likely needs operating improvement before returns quality can be considered durable.

Multiple analysis puts the portfolio at trailing P/E of 19.11, forward P/E of 14.88, PEG of 4.01. Trailing and forward multiples are nearly identical, indicating the market is pricing the portfolio on a relatively static earnings assumption. Growth-adjusted, the portfolio is priced at a premium — a level that demands consistent execution and limits the potential for multiple expansion from here. The current ratio of 3.09 indicates holdings are well-positioned to meet near-term obligations. The combined valuation and liquidity profile points to a portfolio where current prices embed meaningful growth expectations, and where delivery against those expectations will drive the return outcome.

On the margin front: gross margin sits at 43.40%, operating margin at -491.34%, and free cash flow margin at 17.09%. At this level, the portfolio reflects reasonable cost discipline and adequate pricing leverage at the production layer. The operating margin reading is weak, suggesting cost structures are outpacing revenue generation across much of the portfolio. Strong free cash flow margins point to businesses with meaningful financial flexibility and limited dependence on external capital. The margin stack is not uniformly strong, which means the portfolio's earnings resilience under adverse conditions is less certain.

On the forward picture: TTM revenue growth of 24.34% reflecting robust top-line expansion across the underlying holdings. Consensus EPS estimates point to 28.5% earnings growth over the next 12 months — a compelling near-term earnings catalyst that, if delivered, changes the valuation conversation materially. Analyst price targets suggest street expectations imply a constructive but measured return profile on a 12-month view. Revenue growth is grounded in reported results; price targets are forward projections that embed assumptions about multiple expansion, earnings delivery, and macro conditions. The key risk in both directions is whether the underlying businesses can maintain their operating trajectory as macro and sector conditions evolve. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Overall, the setup is mixed enough that patience is probably the right posture until clarity improves on the key variables.

The views expressed above are derived from quantitative data only and should not be relied upon as financial advice. Investment decisions should be based on your own research and risk tolerance.